OptimizeRx Corp
Research OptimizeRx Corp (OPRX) on Bullrun: valuation model: 8.7% undervalued, market cap USD 101.89M, P/E 15.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOPRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal8.7% undervalued
- Market capUSD 101.89M
- P/E15.4
- Financial periodFY2025
- RevenueUSD 109.43M
- Revenue growth18.8%
- Net incomeUSD 5.13M
- Free cash flowUSD 18.66M
- Gross margin67.3%
Valuation Snapshot
Bullrun's latest valuation model marks OptimizeRx Corp as 8.7% undervalued; latest market cap is USD 101.89M; P/E is 15.4.
About OptimizeRx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers;
Frequently asked questions
Is OptimizeRx Corp overvalued or undervalued?
Bullrun's valuation model currently marks OptimizeRx Corp as 8.7% undervalued.
What is OptimizeRx Corp's market cap?
OptimizeRx Corp's market capitalization is USD 101.89M.
What is OptimizeRx Corp's P/E ratio?
OptimizeRx Corp's price-to-earnings (P/E) ratio is 15.4.
What does OptimizeRx Corp do?
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods;